Shawn Novick graduated from New York University and has been working in various positions in the Biotechnology industry for over 30 years, primarily focused on analytical development, characterization, and quality control. She has worked on several clinical and commercial products, including mAbs, ADCs, and other therapeutic proteins. Currently Shawn is a principle consultant with BioPhia Consulting and is a Board member of IABS.